• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacokinetics of clavulanic acid, given in combination with amoxycillin, in volunteers.

作者信息

Nilsson-Ehle I, Fellner H, Hedström S A, Nilsson-Ehle P, Sjövall J

出版信息

J Antimicrob Chemother. 1985 Oct;16(4):491-8. doi: 10.1093/jac/16.4.491.

DOI:10.1093/jac/16.4.491
PMID:4066561
Abstract

To study the absorption and disposition of clavulanic acid, ten healthy men received one intravenous and one oral dose of 125 mg clavulanic acid in combination with amoxycillin. Serum and urine concentrations were measured with high-performance liquid chromatography. The mean terminal half-lives in serum were 0.97 and 0.94 h, respectively. Total serum clearance was 248 +/- 55 ml/min X 1.73 m2. Renal clearance was 108 +/- 20 and 115 +/- 18 ml/min X 1.73 m2 after intravenous and peroral administration. Urinary recovery over 12 h was 49.4 +/- 8.7% of the intravenous and 35.7 +/- 13.0% of the oral dose. The bioavailability of the oral dose averaged 60.0 +/- 23.1% but varied considerably (range 31.4-98.8%), indicating very variable absorption from the gastrointestinal tract.

摘要

相似文献

1
Pharmacokinetics of clavulanic acid, given in combination with amoxycillin, in volunteers.
J Antimicrob Chemother. 1985 Oct;16(4):491-8. doi: 10.1093/jac/16.4.491.
2
Parenteral augmentin: pharmacokinetics.注射用奥格门汀:药代动力学
Int J Clin Pharmacol Ther Toxicol. 1984 Aug;22(8):430-4.
3
The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid.口服吸收的头孢呋辛与阿莫西林/克拉维酸的药代动力学比较。
J Antimicrob Chemother. 1984 Jun;13(6):603-10. doi: 10.1093/jac/13.6.603.
4
Bioavailability and pharmacokinetics of clavulanic acid in healthy subjects.
Int J Clin Pharmacol Ther Toxicol. 1985 Feb;23(2):70-3.
5
Augmentin bioavailability following cimetidine, aluminum hydroxide and milk.西咪替丁、氢氧化铝和牛奶对阿莫西林生物利用度的影响。
Int J Clin Pharmacol Ther Toxicol. 1985 Mar;23(3):154-7.
6
Comparative pharmacokinetics of sulbactam/ampicillin and clavulanic acid/amoxycillin in human volunteers.舒巴坦/氨苄西林与克拉维酸/阿莫西林在人类志愿者中的比较药代动力学。
Drugs. 1988;35 Suppl 7:29-33. doi: 10.2165/00003495-198800357-00007.
7
The penetration of amoxycillin/clavulanic acid into peritoneal fluid.
J Antimicrob Chemother. 1983 Jan;11(1):57-60. doi: 10.1093/jac/11.1.57.
8
Pharmacokinetic study of a paediatric formulation of amoxycillin and clavulanic acid in children.
Eur J Clin Pharmacol. 1985;29(2):235-9. doi: 10.1007/BF00547429.
9
Pharmacokinetics of amoxycillin and clavulanic acid in haemodialysis patients following intravenous administration of Augmentin.静脉注射安灭菌后阿莫西林和克拉维酸在血液透析患者中的药代动力学。
Br J Clin Pharmacol. 1988 Oct;26(4):385-90. doi: 10.1111/j.1365-2125.1988.tb03395.x.
10
Pharmacokinetics and urinary excretion of clavulanic acid after oral administration of amoxicillin and potassium clavulanate.
J Clin Pharmacol. 1984 Oct;24(10):452-6. doi: 10.1002/j.1552-4604.1984.tb01818.x.

引用本文的文献

1
A Pooled Population Pharmacokinetic Study of Oral and Intravenous Administration of Clavulanic Acid in Neonates and Infants: Targeting Effective Beta-Lactamase Inhibition.新生儿和婴儿口服及静脉注射克拉维酸的群体药代动力学研究:以有效抑制β-内酰胺酶为目标
Clin Pharmacol Ther. 2025 Jan;117(1):193-202. doi: 10.1002/cpt.3423. Epub 2024 Aug 28.
2
Pharmacokinetics of Clavulanic Acid in the Pediatric Population: A Systematic Literature Review.儿童人群中克拉维酸的药代动力学:系统文献回顾。
Clin Pharmacokinet. 2022 May;61(5):637-653. doi: 10.1007/s40262-022-01116-3. Epub 2022 Mar 31.
3
Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.
头孢噻肟与阿莫西林-克拉维酸对产超广谱β-内酰胺酶大肠埃希菌在小鼠尿路感染模型中的协同作用。
Antimicrob Agents Chemother. 2015 Nov 2;60(1):424-30. doi: 10.1128/AAC.02018-15. Print 2016 Jan.
4
Detection of favorable oral cephalosporin-clavulanate interactions by in vitro disk approximation susceptibility testing of extended-spectrum-Beta-lactamase-producing members of the enterobacteriaceae.通过对产超广谱β-内酰胺酶的肠杆菌科成员进行体外磁盘近似药敏试验来检测有利的口腔头孢菌素-克拉维酸相互作用。
J Clin Microbiol. 2012 Mar;50(3):1023-6. doi: 10.1128/JCM.06248-11. Epub 2011 Dec 14.
5
Bone penetration of amoxicillin and clavulanic acid evaluated by population pharmacokinetics and Monte Carlo simulation.通过群体药代动力学和蒙特卡洛模拟评估阿莫西林和克拉维酸的骨穿透性。
Antimicrob Agents Chemother. 2009 Jun;53(6):2569-78. doi: 10.1128/AAC.01119-08. Epub 2009 Mar 23.
6
Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.抗菌化疗中酶抑制剂的临床药代动力学
Clin Pharmacokinet. 1988 Sep;15(3):133-64. doi: 10.2165/00003088-198815030-00001.
7
Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.阿莫西林/克拉维酸:抗菌活性、药代动力学特性及治疗用途的最新进展
Drugs. 1990 Feb;39(2):264-307. doi: 10.2165/00003495-199039020-00008.